FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312019379> ?p ?o ?g. }

• W4312019379 endingPage "E1609" @default.
• W4312019379 startingPage "E1599" @default.
• W4312019379 abstract "The evolving proportion of the population considered immunologically naive versus primed for more efficient immune memory response to SARS-CoV-2 has implications for risk assessment. We sought to chronicle vaccine- and infection-induced seroprevalence across the first 7 waves of the COVID-19 pandemic in British Columbia, Canada.During 8 cross-sectional serosurveys conducted between March 2020 and August 2022, we obtained anonymized residual sera from children and adults who attended an outpatient laboratory network in the Lower Mainland (Greater Vancouver and Fraser Valley). We used at least 3 immunoassays per serosurvey to detect SARS-CoV-2 spike and nucleocapsid antibodies. We assessed any seroprevalence (vaccineor infection-induced, or both), defined by positivity on any 2 assays, and infection-induced seroprevalence, also defined by dual-assay positivity but requiring both antinucleocapsid and antispike detection. We used estimates of infection-induced seroprevalence to explore underascertainment of infections by surveillance case reports.By January 2021, we estimated that any seroprevalence remained less than 5%, increasing with vaccine rollout to 56% by May-June 2021, 83% by September-October 2021 and 95% by March 2022. Infection-induced seroprevalence remained less than 15% through September-October 2021, increasing across Omicron waves to 42% by March 2022 and 61% by July-August 2022. By August 2022, 70%-80% of children younger than 20 years and 60%-70% of adults aged 20-59 years had been infected, but fewer than half of adults aged 60 years and older had been infected. Compared with estimates of infection-induced seroprevalence, surveillance case reports underestimated infections 12-fold between September 2021 and March 2022 and 92-fold between March 2022 and August 2022.By August 2022, most children and adults younger than 60 years had evidence of both SARS-CoV-2 vaccination and infection. As previous evidence suggests that a history of both exposures may induce stronger, more durable hybrid immunity than either exposure alone, older adults - who have the lowest infection rates but highest risk of severe outcomes - continue to warrant prioritized vaccination." @default.
• W4312019379 created "2023-01-03" @default.
• W4312019379 creator A5000729511 @default.
• W4312019379 creator A5010208879 @default.
• W4312019379 creator A5012876179 @default.
• W4312019379 creator A5025142115 @default.
• W4312019379 creator A5029768238 @default.
• W4312019379 creator A5039117942 @default.
• W4312019379 creator A5049170898 @default.
• W4312019379 creator A5052643110 @default.
• W4312019379 creator A5053817611 @default.
• W4312019379 creator A5064297603 @default.
• W4312019379 creator A5079171066 @default.
• W4312019379 creator A5083391323 @default.
• W4312019379 creator A5086578132 @default.
• W4312019379 date "2022-12-04" @default.
• W4312019379 modified "2023-10-01" @default.
• W4312019379 title "Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada" @default.
• W4312019379 cites W1632204375 @default.
• W4312019379 cites W1971279413 @default.
• W4312019379 cites W1971381801 @default.
• W4312019379 cites W2011888687 @default.
• W4312019379 cites W2097399384 @default.
• W4312019379 cites W2110586663 @default.
• W4312019379 cites W2112601491 @default.
• W4312019379 cites W2159301256 @default.
• W4312019379 cites W2161944342 @default.
• W4312019379 cites W2203488740 @default.
• W4312019379 cites W2797649541 @default.
• W4312019379 cites W3035189381 @default.
• W4312019379 cites W3084370888 @default.
• W4312019379 cites W3133439220 @default.
• W4312019379 cites W3147460296 @default.
• W4312019379 cites W3165522334 @default.
• W4312019379 cites W3184432719 @default.
• W4312019379 cites W3188666920 @default.
• W4312019379 cites W3192048703 @default.
• W4312019379 cites W3200935677 @default.
• W4312019379 cites W3213931931 @default.
• W4312019379 cites W3217449531 @default.
• W4312019379 cites W4205506224 @default.
• W4312019379 cites W4206056256 @default.
• W4312019379 cites W4212835565 @default.
• W4312019379 cites W4213246071 @default.
• W4312019379 cites W4213383641 @default.
• W4312019379 cites W4223653778 @default.
• W4312019379 cites W4280643719 @default.
• W4312019379 cites W4281557772 @default.
• W4312019379 cites W4282958946 @default.
• W4312019379 cites W4283319609 @default.
• W4312019379 cites W4283324651 @default.
• W4312019379 cites W4283808736 @default.
• W4312019379 cites W4285494316 @default.
• W4312019379 cites W4289261408 @default.
• W4312019379 cites W4291020805 @default.
• W4312019379 cites W4292104160 @default.
• W4312019379 cites W4296577980 @default.
• W4312019379 cites W4306178427 @default.
• W4312019379 cites W4306729513 @default.
• W4312019379 doi "https://doi.org/10.1503/cmaj.221335" @default.
• W4312019379 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36507788" @default.
• W4312019379 hasPublicationYear "2022" @default.
• W4312019379 type Work @default.
• W4312019379 citedByCount "21" @default.
• W4312019379 countsByYear W43120193792022 @default.
• W4312019379 countsByYear W43120193792023 @default.
• W4312019379 crossrefType "journal-article" @default.
• W4312019379 hasAuthorship W4312019379A5000729511 @default.
• W4312019379 hasAuthorship W4312019379A5010208879 @default.
• W4312019379 hasAuthorship W4312019379A5012876179 @default.
• W4312019379 hasAuthorship W4312019379A5025142115 @default.
• W4312019379 hasAuthorship W4312019379A5029768238 @default.
• W4312019379 hasAuthorship W4312019379A5039117942 @default.
• W4312019379 hasAuthorship W4312019379A5049170898 @default.
• W4312019379 hasAuthorship W4312019379A5052643110 @default.
• W4312019379 hasAuthorship W4312019379A5053817611 @default.
• W4312019379 hasAuthorship W4312019379A5064297603 @default.
• W4312019379 hasAuthorship W4312019379A5079171066 @default.
• W4312019379 hasAuthorship W4312019379A5083391323 @default.
• W4312019379 hasAuthorship W4312019379A5086578132 @default.
• W4312019379 hasBestOaLocation W43120193791 @default.
• W4312019379 hasConcept C107130276 @default.
• W4312019379 hasConcept C126322002 @default.
• W4312019379 hasConcept C142052008 @default.
• W4312019379 hasConcept C142724271 @default.
• W4312019379 hasConcept C144024400 @default.
• W4312019379 hasConcept C149923435 @default.
• W4312019379 hasConcept C159047783 @default.
• W4312019379 hasConcept C159654299 @default.
• W4312019379 hasConcept C203014093 @default.
• W4312019379 hasConcept C2778494684 @default.
• W4312019379 hasConcept C2779134260 @default.
• W4312019379 hasConcept C2908647359 @default.
• W4312019379 hasConcept C3007834351 @default.
• W4312019379 hasConcept C3008058167 @default.
• W4312019379 hasConcept C45189115 @default.
• W4312019379 hasConcept C524204448 @default.
• W4312019379 hasConcept C71924100 @default.

• next